This drug halved cholesterol levels in clinical trials
– From goodluz / Shutterstock.com In a Phase 2 clinical trial, researchers at the Mount Sinai School of Medicine found that a drug called evinacumab was able to halve cholesterol levels in patients with high cholesterol. A monoclonal antibody to lower LDL levels Although cholesterol is an essential component of cells, a certain type known … Read more